SCHEMBL25848272

SCHEMBL25848272

C=CC(=O)OC1CCC(Oc2ccc3cc(-c4ccc(OC)cc4OC(F)(F)F)c(=O)oc3c2)C1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
MAOB P27338 6/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 2/20 0.37
GAA P10253 2/20 0.37
SLC16A3 O15427 1/20 0.37
ALK Q9UM73 1/20 0.36
MAPT P10636 2/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAOA P21397 2/20 0.36
RXFP1 Q9HBX9 2/20 0.36
GLA P06280 1/20 0.35
MEN1 O00255 1/20 0.35
MIF P14174 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625384 0.92 RAB9A (0.38) RAB9ANPC1MAOBALDH1A1HPGD
SCHEMBL25848273 0.89 MAOB (0.39) RAB9ANPC1MAOBALDH1A1HPGD
SCHEMBL25848270 0.87 RAB9A (0.41) RAB9ANPC1MAOBALDH1A1HPGD
SCHEMBL25848265 0.87 THRB (0.37) RAB9ANPC1MAOBALDH1A1HPGD
SCHEMBL25848299 0.85 RAB9A (0.38) RAB9ANPC1MAOBALDH1A1HPGD
SCHEMBL22625020 0.84 RAB9A (0.36) RAB9ANPC1MAOBALDH1A1HPGD
SCHEMBL22625053 0.81 MAOB (0.39) RAB9ANPC1MAOBALDH1A1HPGD
SCHEMBL22625405 0.81 RAB9A (0.39) RAB9ANPC1MAOBALDH1A1HPGD
SCHEMBL25848267 0.80 THRB (0.39) RAB9ANPC1MAOBALDH1A1HPGD
SCHEMBL25848248 0.80 NPC1 (0.53) RAB9ANPC1MAOBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 RAB9A 1916/4885NPC1 1051/4885MAOB 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.